![Mikko Lauri Sampsa Mannerkoski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mikko Lauri Sampsa Mannerkoski
Oprichter bij Rappta Therapeutics Oy
Actieve functies van Mikko Lauri Sampsa Mannerkoski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mandatum & Co. Oy
![]() Mandatum & Co. Oy Life/Health InsuranceFinance Mandatum & Co. Oy provides investment advice for Finnish insurance company portfolios. | Corporate Officer/Principal | 14-09-2010 | - |
Aventum Oy
![]() Aventum Oy Miscellaneous Commercial ServicesCommercial Services Aventum Oy provides advisory services within mergers and acquisitions, capital market and real estate transactions, and financial advisory. It serves private and public Finland-based corporations and institutions, private equity investors, and international industrial and financial investors active in Finland. The company was founded by Olli Markus Klemola, Harry Heikki Palmroth, Juha Petri Ruohela, and Mikko Lauri Sampsa Mannerkoski on August 29, 2003 and is headquartered in Helsinki, Finland. | Oprichter | 29-08-2003 | - |
Corporate Officer/Principal | 29-08-2003 | - | |
Rappta Therapeutics Oy
![]() Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Financieel Directeur/CFO | 15-09-2021 | - |
Oprichter | 20-03-2019 | - | |
Directeur/Bestuurslid | 20-03-2019 | - | |
Algemeen Directeur | 20-03-2019 | 15-09-2021 |
Loopbaan van Mikko Lauri Sampsa Mannerkoski
Eerdere bekende functies van Mikko Lauri Sampsa Mannerkoski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aventum Partners Oy
![]() Aventum Partners Oy Investment ManagersFinance Aventum Partners Oy provides advisory services in merger & acquisition and capital market transactions as well as in corporate restructurings. The firm also provides corporate divestures, asset purchase, equity raising, valuation & fairness opinion, and legal consulting services. The company was founded by Mikko Lauri Sampsa Mannerkoski in 2003 and is headquartered in Helsinki, Finland. | Oprichter | 01-01-2003 | - |
Statistieken
Internationaal
Finland | 5 |
Operationeel
Founder | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectoraal
Finance | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Aventum Partners Oy
![]() Aventum Partners Oy Investment ManagersFinance Aventum Partners Oy provides advisory services in merger & acquisition and capital market transactions as well as in corporate restructurings. The firm also provides corporate divestures, asset purchase, equity raising, valuation & fairness opinion, and legal consulting services. The company was founded by Mikko Lauri Sampsa Mannerkoski in 2003 and is headquartered in Helsinki, Finland. | Finance |
Mandatum & Co. Oy
![]() Mandatum & Co. Oy Life/Health InsuranceFinance Mandatum & Co. Oy provides investment advice for Finnish insurance company portfolios. | Finance |
Aventum Oy
![]() Aventum Oy Miscellaneous Commercial ServicesCommercial Services Aventum Oy provides advisory services within mergers and acquisitions, capital market and real estate transactions, and financial advisory. It serves private and public Finland-based corporations and institutions, private equity investors, and international industrial and financial investors active in Finland. The company was founded by Olli Markus Klemola, Harry Heikki Palmroth, Juha Petri Ruohela, and Mikko Lauri Sampsa Mannerkoski on August 29, 2003 and is headquartered in Helsinki, Finland. | Commercial Services |
Rappta Therapeutics Oy
![]() Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |